140 related articles for article (PubMed ID: 36889064)
1. Peroxisome proliferator-activated receptor ɣ agonist mediated inhibition of heparanase expression reduces proteinuria.
Garsen M; Buijsers B; Sol M; Gockeln L; Sonneveld R; van Kuppevelt TH; de Graaf M; van den Born J; Kamps JAAM; van Raalte DH; van der Meer RW; Lamb HJ; Hillebrands JL; Rabelink TJ; Maciej-Hulme ML; Krenning G; Nijenhuis T; van der Vlag J
EBioMedicine; 2023 Apr; 90():104506. PubMed ID: 36889064
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional regulation of nephrin gene by peroxisome proliferator-activated receptor-gamma agonist: molecular mechanism of the antiproteinuric effect of pioglitazone.
Benigni A; Zoja C; Tomasoni S; Campana M; Corna D; Zanchi C; Gagliardini E; Garofano E; Rottoli D; Ito T; Remuzzi G
J Am Soc Nephrol; 2006 Jun; 17(6):1624-32. PubMed ID: 16687628
[TBL] [Abstract][Full Text] [Related]
3. Pioglitazone, a PPARγ agonist, provides comparable protection to angiotensin converting enzyme inhibitor ramipril against adriamycin nephropathy in rat.
Ochodnicky P; Mesarosova L; Cernecka H; Klimas J; Krenek P; Goris M; van Dokkum RP; Henning RH; Kyselovic J
Eur J Pharmacol; 2014 May; 730():51-60. PubMed ID: 24582928
[TBL] [Abstract][Full Text] [Related]
4. Sildenafil Prevents Podocyte Injury
Sonneveld R; Hoenderop JG; Isidori AM; Henique C; Dijkman HB; Berden JH; Tharaux PL; van der Vlag J; Nijenhuis T
J Am Soc Nephrol; 2017 May; 28(5):1491-1505. PubMed ID: 27895156
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D attenuates proteinuria by inhibition of heparanase expression in the podocyte.
Garsen M; Sonneveld R; Rops AL; Huntink S; van Kuppevelt TH; Rabelink TJ; Hoenderop JG; Berden JH; Nijenhuis T; van der Vlag J
J Pathol; 2015 Dec; 237(4):472-81. PubMed ID: 26202309
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effects of peroxisome proliferator-activated receptor γ agonists on collagen IV production in podocytes.
Li Y; Shen Y; Li M; Su D; Xu W; Liang X; Li R
Mol Cell Biochem; 2015 Jul; 405(1-2):233-41. PubMed ID: 25920446
[TBL] [Abstract][Full Text] [Related]
7. Reduction of renal lipid content and proteinuria by a PPAR-γ agonist in a rat model of angiotensin II-induced hypertension.
Sakamoto A; Hongo M; Saito K; Nagai R; Ishizaka N
Eur J Pharmacol; 2012 May; 682(1-3):131-6. PubMed ID: 22387860
[TBL] [Abstract][Full Text] [Related]
8. The peroxisome proliferator-activated receptor-gamma agonist pioglitazone represses inflammation in a peroxisome proliferator-activated receptor-alpha-dependent manner in vitro and in vivo in mice.
Orasanu G; Ziouzenkova O; Devchand PR; Nehra V; Hamdy O; Horton ES; Plutzky J
J Am Coll Cardiol; 2008 Sep; 52(10):869-81. PubMed ID: 18755353
[TBL] [Abstract][Full Text] [Related]
9. Thiazolidinedione ameliorates renal injury in experimental diabetic rats through anti-inflammatory effects mediated by inhibition of NF-kappaB activation.
Ohga S; Shikata K; Yozai K; Okada S; Ogawa D; Usui H; Wada J; Shikata Y; Makino H
Am J Physiol Renal Physiol; 2007 Apr; 292(4):F1141-50. PubMed ID: 17190910
[TBL] [Abstract][Full Text] [Related]
10. Proinflammatory stimulation and pioglitazone treatment regulate peroxisome proliferator-activated receptor gamma levels in peripheral blood mononuclear cells from healthy controls and multiple sclerosis patients.
Klotz L; Schmidt M; Giese T; Sastre M; Knolle P; Klockgether T; Heneka MT
J Immunol; 2005 Oct; 175(8):4948-55. PubMed ID: 16210596
[TBL] [Abstract][Full Text] [Related]
11. The protective role of peroxisome proliferator-activated receptor gamma in lipotoxic podocytes.
Carrasco AG; Izquierdo-Lahuerta A; Valverde ÁM; Ni L; Flores-Salguero E; Coward RJ; Medina-Gómez G
Biochim Biophys Acta Mol Cell Biol Lipids; 2023 Jul; 1868(7):159329. PubMed ID: 37156296
[TBL] [Abstract][Full Text] [Related]
12. Crosstalk between peroxisome proliferator-activated receptor-γ and mineralcorticoid receptor in TNF-α activated renal tubular cell.
Xiao J; Chen W; Lu Y; Zhang X; Fu C; Yan Z; Zhang Z; Ye Z
Inflamm Res; 2015 Aug; 64(8):603-14. PubMed ID: 26072064
[TBL] [Abstract][Full Text] [Related]
13. Peroxisome proliferator-activated receptor-γ agonist pioglitazone fails to attenuate renal fibrosis caused by unilateral ureteral obstruction in mice.
Zhang Y; Wang J; Zhou QD; Zhang CH; Li Q; Huang S; Zhan J; Wang K; Liu YY; Xu G
J Huazhong Univ Sci Technolog Med Sci; 2016 Feb; 36(1):41-47. PubMed ID: 26838738
[TBL] [Abstract][Full Text] [Related]
14. The peroxisome proliferator-activated receptor-γ agonist pioglitazone protects against cisplatin-induced renal damage in mice.
Jesse CR; Bortolatto CF; Wilhelm EA; Roman SS; Prigol M; Nogueira CW
J Appl Toxicol; 2014 Jan; 34(1):25-32. PubMed ID: 22987311
[TBL] [Abstract][Full Text] [Related]
15. The PPARgamma agonist pioglitazone ameliorates aging-related progressive renal injury.
Yang HC; Deleuze S; Zuo Y; Potthoff SA; Ma LJ; Fogo AB
J Am Soc Nephrol; 2009 Nov; 20(11):2380-8. PubMed ID: 19797472
[TBL] [Abstract][Full Text] [Related]
16. Protective effects of PPARγ agonist in acute nephrotic syndrome.
Zuo Y; Yang HC; Potthoff SA; Najafian B; Kon V; Ma LJ; Fogo AB
Nephrol Dial Transplant; 2012 Jan; 27(1):174-81. PubMed ID: 21565943
[TBL] [Abstract][Full Text] [Related]
17. Vitamin D down-regulates TRPC6 expression in podocyte injury and proteinuric glomerular disease.
Sonneveld R; Ferrè S; Hoenderop JG; Dijkman HB; Berden JH; Bindels RJ; Wetzels JF; van der Vlag J; Nijenhuis T
Am J Pathol; 2013 Apr; 182(4):1196-204. PubMed ID: 23385000
[TBL] [Abstract][Full Text] [Related]
18. Endothelin-1 Induces Proteinuria by Heparanase-Mediated Disruption of the Glomerular Glycocalyx.
Garsen M; Lenoir O; Rops AL; Dijkman HB; Willemsen B; van Kuppevelt TH; Rabelink TJ; Berden JH; Tharaux PL; van der Vlag J
J Am Soc Nephrol; 2016 Dec; 27(12):3545-3551. PubMed ID: 27026367
[TBL] [Abstract][Full Text] [Related]
19. Effects of the dual peroxisome proliferator-activated receptor-α/γ agonist aleglitazar on renal function in patients with stage 3 chronic kidney disease and type 2 diabetes: a Phase IIb, randomized study.
Ruilope L; Hanefeld M; Lincoff AM; Viberti G; Meyer-Reigner S; Mudie N; Wieczorek Kirk D; Malmberg K; Herz M
BMC Nephrol; 2014 Nov; 15():180. PubMed ID: 25407798
[TBL] [Abstract][Full Text] [Related]
20. Involvement of glucocorticoid receptor and peroxisome proliferator activated receptor-gamma in pioglitazone mediated chronic gastric ulcer healing in rats.
Lahiri S; Sen T; Palit G
Eur J Pharmacol; 2009 May; 609(1-3):118-25. PubMed ID: 19281808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
